Literature DB >> 16305591

Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

A Vallano1, G Cereza, C Pedròs, A Agustí, I Danés, C Aguilera, J M Arnau.   

Abstract

AIM: To describe the opinions of hospital physicians concerning problems regarding the spontaneous reporting of adverse drug reactions (ADRs) and ways to solve them.
METHODS: A qualitative study was carried out. Fifteen focus groups were conducted among physicians working in a tertiary teaching hospital. A total of 208 physicians from different medical specialities participated. The focus group discussions were recorded by three different observers and the transcripts of each session were analysed for issues and themes emerging from the text.
RESULTS: Four types of obstacles to spontaneous reporting were considered particularly important: (i) problems with the ADR(S) diagnosis; (ii) problems with the usual workload and lack of time; (iii) problems related to the organization and activities of the pharmacovigilance system; (iv) and problems related to potential conflicts. The potential solutions suggested for improving spontaneous reporting were to define the kind of ADR(S) which should be reported, to facilitate an easy contact and quick access to the hospital pharmacovigilance system, to facilitate information and support for reporting and feedback of pharmacovigilance activities.
CONCLUSIONS: The perception of the different obstacles by the hospital physicians is an important factor in determining the causes of the underreporting of ADRs and addressing these obstacles could lead to an improvement in spontaneous reporting. A closer relationship between the doctors and the pharmacovigilance centre is suggested as a means of solving these problems. More information is needed to improve the spontaneous reporting of ADR(S) in specialized healthcare.

Mesh:

Year:  2005        PMID: 16305591      PMCID: PMC1884880          DOI: 10.1111/j.1365-2125.2005.02504.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Attitudes to reporting adverse drug reactions in northern Sweden.

Authors:  M Bäckström; T Mjörndal; R Dahlqvist; T Nordkvist-Olsson
Journal:  Eur J Clin Pharmacol       Date:  2000-12       Impact factor: 2.953

2.  Physicians' attitudes towards voluntary reporting of adverse drug events.

Authors:  A Figueiras; F Tato; J Fontaiñas; B Takkouche; J J Gestal-Otero
Journal:  J Eval Clin Pract       Date:  2001-11       Impact factor: 2.431

3.  Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions.

Authors:  J Hasford; M Goettler; K-H Munter; B Müller-Oerlinghausen
Journal:  J Clin Epidemiol       Date:  2002-09       Impact factor: 6.437

4.  Attitudes to adverse drug reaction reporting in the Northern Region.

Authors:  D N Bateman; G L Sanders; M D Rawlins
Journal:  Br J Clin Pharmacol       Date:  1992-11       Impact factor: 4.335

5.  Reasons for reporting adverse drug reactions--some thoughts based on an international review.

Authors:  C Biriell; I R Edwards
Journal:  Pharmacoepidemiol Drug Saf       Date:  1997-01       Impact factor: 2.890

6.  150 years of pharmacovigilance.

Authors:  P Routledge
Journal:  Lancet       Date:  1998-04-18       Impact factor: 79.321

7.  Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group.

Authors:  K J Belton
Journal:  Eur J Clin Pharmacol       Date:  1997       Impact factor: 2.953

8.  Reporting of adverse drug reactions by hospital doctors and the response to intervention.

Authors:  P McGettigan; J Golden; R M Conroy; N Arthur; J Feely
Journal:  Br J Clin Pharmacol       Date:  1997-07       Impact factor: 4.335

Review 9.  Rigour and qualitative research.

Authors:  N Mays; C Pope
Journal:  BMJ       Date:  1995-07-08

10.  Qualitative research. Introducing focus groups.

Authors:  J Kitzinger
Journal:  BMJ       Date:  1995-07-29
View more
  58 in total

Review 1.  Determinants of under-reporting of adverse drug reactions: a systematic review.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

2.  An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

Authors:  Consuelo Pedrós; Antoni Vallano; Gloria Cereza; Gemma Mendoza-Aran; Antònia Agustí; Cristina Aguilera; Immaculada Danés; Xavier Vidal; Josep M Arnau
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

3.  Perception on adverse drug reaction reporting by physicians working in southern romania.

Authors:  Marian Sorin Paveliu; Simona Bengea-Luculescu; Mihai Toma; Silvia Fraga Paveliu
Journal:  Maedica (Bucur)       Date:  2013-03

4.  Risk perception and reasons for noncompliance in pharmacovigilance: a qualitative study conducted in Canada.

Authors:  Vincent Nichols; Isabelle Thériault-Dubé; Julie Touzin; Jean-François Delisle; Denis Lebel; Jean-François Bussières; Benoît Bailey; Johanne Collin
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

5.  Pharmacy students' knowledge and perceptions about pharmacovigilance in Malaysian public universities.

Authors:  Ramadan Mohamed Elkalmi; Mohamed Azmi Hassali; Mohamed Izham M Ibrahim; Riyanto T Widodo; Qais M A Efan; Muhammad Abdul Hadi
Journal:  Am J Pharm Educ       Date:  2011-06-10       Impact factor: 2.047

6.  Knowledge, Attitudes, and Practices of Health Care Professionals Toward Adverse Drug Reaction Reporting in Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia: A Cross-sectional Study.

Authors:  Hussen Shanko; Jemal Abdela
Journal:  Hosp Pharm       Date:  2017-10-25

7.  Pharmacy students' attitudes toward reporting serious adverse drug events.

Authors:  Paul Gavaza; Bihn Bui
Journal:  Am J Pharm Educ       Date:  2012-12-12       Impact factor: 2.047

8.  Pharmacovigilance systems in developing countries: an evaluative case study in Burkina Faso.

Authors:  Lassane Kabore; Pascal Millet; Souleymane Fofana; Driss Berdai; Caroline Adam; Françoise Haramburu
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

9.  Perceptions of doctors to adverse drug reaction reporting in a teaching hospital in Lagos, Nigeria.

Authors:  Kazeem A Oshikoya; Jacob O Awobusuyi
Journal:  BMC Clin Pharmacol       Date:  2009-08-11

10.  Information and feedback to improve occupational physicians' reporting of occupational diseases: a randomised controlled trial.

Authors:  Annet F Lenderink; Dick Spreeuwers; Jac J L van der Klink; Frank J H van Dijk
Journal:  Int Arch Occup Environ Health       Date:  2009-10-15       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.